Table 4 Comparison between COPD patients with and without albuminuria according to physiological data.
From: Albuminuria as a non-invasive biomarker of endothelial dysfunction in patients with COPD
|  | Total (n = 60) | Patients with albuminuria (n = 16) | Patients without albuminuria (n = 44) | P |
|---|---|---|---|---|
Post-BD FEV1 (%pred) | 59.9 ± 20.7a | 58.6 ± 20.9a | 60.3 ± 21a | 0.802 |
Post-BD FVC (%pred) | 79.4 ± 19.8a | 75.9 ± 17.5a | 80.6 ± 20.6a | 0.489 |
Post-BD FEV1/FVC | 59.6 (54.2–65.1)b | 59.5 (54.2–63.8)b | 62.9 (52.3–65.3)b | 0.617 |
Bronchodilator response (% change in FEV1) | 6 (0–17)b | 5.6 (0.4–17.3)b | 9.6 (0–17)b | 0.980 |
Post-BD PEF (%pred) | 50.8 ± 22.3a | 50.5 ± 22.6a | 51.4 ± 22.4a | 0.916 |
Post-BD FEF75% (%pred) | 29.5 ± 15.6a | 28.5 ± 12.8a | 32.3 ± 22.2a | 0.587 |
Post-BD FEF25−75% | 31.4 ± 17.9a | 30.5 ± 15.7a | 34 ± 23.6a | 0.567 |
HR (beat/min) | 74.5 ± 10.1a | 79 ± 10.7a | 72.9 ± 9.6a | 0.075 |
Systolic ABP (mm Hg) | 120 ± 14.3a | 123.3 ± 15.1a | 118.8 ± 14.1a | 0.288 |
Diastolic ABP (mm Hg) | 80.2 ± 9.1a | 82.3 ± 9.1a | 79.4 ± 9.2a | 0.283 |
SpO2% | 94.70 ± 2.60a | 91.25 ± 1.86a | 95.91 ± 1.48a | < 0.001* |
6MWD (m) | 138.5 (120–190)b | 138.5 (120–190)b | 142 (128.5–181.5)b | 0.802 |
BODE Index | 4.9 ± 2.5a | 4.5 ± 2a | 5 ± 2.7a | 0.563 |
FMD (% change in brachial artery diameter) | 4.13 ± 1.23a | 3.35 ± 0.94a | 4.52 ± 1.38a | 0.003* |